Mednet Logo

What is your preferred treatment for Stage IIA seminoma or IIB seminoma with LN <3 cm and normal tumor markers after orchiectomy?

Does patient age effect your approach? Would you consider RPLND for any patients in light of the phase II SEMS trial presented at the 2021 ASCO GU Cancers Symposium?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Rutgers Cancer Institute of New Jersey
Answered on

Para-aortic nodal disease <5 cm is well treated with radiotherapy to PA+pelvis with boost tot eh nodes with high cure rates and minimal toxicity. >5cm best treated with BEP or EP chemotherapy. No role for RPLND in seminoma.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Testicular Cancer Commons
Answered on

The challenge in small volume stage II seminoma is the same as in non-seminoma but likely worse. We know that in marker negative small volume stage II non-seminoma that the false positive rate of clinical assessments (primarily CT) can be up to 40%. If therapy, either radiation or chemotherapy, is i...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Case Western Reserve University
Answered on

Agree, however, we can't over-interpret the SEMS trial (very small sample size; n= 55). I do favor CDDP-based chemotherapy to most patients with IIB (LNs>2 and <5cm).

Join for free or sign in to see the full answer